Adam R Wende Selected Research

Adam R Wende Research Topics

Disease

13	Heart Failure 01/2024 - 09/2011
11	Cardiomegaly (Heart Hypertrophy) 10/2023 - 10/2007
10	Mitochondrial Diseases (Mitochondrial Disease) 10/2023 - 08/2010
10	Obesity 01/2023 - 03/2010
9	Hypertrophy 01/2022 - 11/2008
7	Type 2 Diabetes Mellitus (MODY) 01/2023 - 12/2007
6	Hypoxia (Hypoxemia) 01/2024 - 08/2011
6	Fibrosis (Cirrhosis) 10/2023 - 08/2010
6	Insulin Resistance 01/2022 - 03/2010
5	Ischemia 01/2021 - 08/2011
4	Diabetes Mellitus 01/2021 - 07/2010
3	Diabetic Cardiomyopathies 12/2022 - 02/2017
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 02/2017
3	Left Ventricular Dysfunction 01/2020 - 01/2011
2	Heart Diseases (Heart Disease) 01/2022 - 02/2017
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 08/2010
2	Glucose Intolerance 01/2020 - 01/2018
2	Body Weight (Weight, Body) 01/2018 - 01/2011
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2023
1	Leukemia 10/2023
1	Sepsis (Septicemia) 01/2023
1	Atrophy 01/2023
1	Dysferlinopathy 01/2023
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2023
1	Vitamin A Deficiency 12/2022
1	Cardiomyopathies (Cardiomyopathy) 12/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Cardiogenic Shock 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Neoplasms (Cancer) 10/2021
1	Carcinoma (Carcinomatosis) 10/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021
1	Hyperglycemia 10/2020
1	Ventricular Remodeling 01/2020
1	Diabetes Complications 01/2019
1	Coronary Disease (Coronary Heart Disease) 01/2019

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 10/2023 - 08/2011
10	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 09/2011
9	Insulin (Novolin)FDA Link 01/2020 - 12/2007
5	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 10/2007
5	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2020 - 02/2012
3	RNA (Ribonucleic Acid)IBA 12/2022 - 01/2019
3	AntioxidantsIBA 01/2020 - 02/2012
3	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2019 - 02/2017
3	LipidsIBA 01/2018 - 03/2010
3	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2017 - 08/2010
2	AcetylglucosamineIBA 10/2023 - 02/2017
2	Vitamin A (Retinol)FDA LinkGeneric 01/2023 - 12/2022
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2022 - 01/2022
2	Hormones (Hormone)IBA 01/2022 - 01/2022
2	fibroblast growth factor 21IBA 01/2022 - 01/2018
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 01/2013
2	KetonesIBA 01/2020 - 06/2017
2	mitoquinoneIBA 01/2020 - 01/2019
2	Insulin ReceptorIBA 01/2020 - 01/2011
2	Streptozocin (Streptozotocin)FDA Link 01/2020 - 07/2010
2	Adiponectin ReceptorsIBA 01/2019 - 01/2015
2	AdiponectinIBA 01/2019 - 01/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 02/2017
2	Phosphotransferases (Kinase)IBA 01/2018 - 12/2017
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 08/2014 - 12/2007
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2013 - 10/2007
1	Messenger RNA (mRNA)IBA 01/2024
1	Tyrosine Kinase InhibitorsIBA 10/2023
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2023
1	aporphineIBA 01/2023
1	boldineIBA 01/2023
1	lecithin-retinol acyltransferaseIBA 12/2022
1	Heparin (Liquaemin)FDA LinkGeneric 01/2022
1	A-factor (Streptomyces)IBA 01/2022
1	Phosphates (Orthophosphate)IBA 01/2022
1	Fibroblast Growth Factor-23IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	CollagenIBA 10/2021
1	Metformin (Glucophage)FDA LinkGeneric 10/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Branched-Chain Amino AcidsIBA 01/2021
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 01/2021
1	Hydroxybutyrate Dehydrogenase (3 Hydroxybutyrate Dehydrogenase)IBA 01/2020
1	Coenzyme A (CoA)IBA 01/2020
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	hexosaminidase CIBA 01/2020
1	TransferasesIBA 01/2020
1	succinyl-coenzyme A (succinyl-CoA)IBA 01/2020
1	Nuclear Respiratory Factor 1IBA 10/2019
1	empagliflozinIBA 02/2019
1	MethyltransferasesIBA 01/2019
1	NADPH Oxidase 4IBA 01/2019
1	EnzymesIBA 01/2019
1	Glucagon (Glukagon)FDA Link 01/2018
1	IUB288IBA 01/2018

Therapy/Procedure

5	Therapeutics 01/2023 - 01/2018
2	Glycemic Control 01/2021 - 02/2017
1	Heart-Assist Devices 01/2024
1	Renal Dialysis (Hemodialysis) 01/2022
1	Highly Active Antiretroviral Therapy (HAART) 01/2018